Literature DB >> 21925001

Minimizing complications in autoimmune blistering diseases.

Tiffany Clay1, Amit G Pandya.   

Abstract

Autoimmune blistering diseases (AIBD) often require high-dose corticosteroids and immunosuppressive agents for adequate control. These diseases cause significant morbidity but treatment can also lead to side effects and complications. This article reviews the supportive management of AIBD and the management of corticosteroid-induced side effects. The prevention and management of secondary effects from some of the more commonly used steroid-sparing agents for AIBD are summarized. Clinicians must be familiar with this information to optimally manage patients with AIBD.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21925001     DOI: 10.1016/j.det.2011.06.005

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  4 in total

1.  Assessing quality of life in patients with autoimmune bullous diseases using the Persian version of Treatment of Autoimmune Bullous Disease Quality of Life questionnaire finds similar effects in women as men.

Authors:  Atefeh Behkar; Gholamreza Garmaroudi; Maryam Nasimi; Shakiba Yousefi; Hasan Khosravi; Nika Kianfar; Dedee F Murrell; Maryam Daneshpazhooh
Journal:  Int J Womens Dermatol       Date:  2022-03-21

Review 2.  Autoimmune blistering diseases in females: a review.

Authors:  Cathy Y Zhao; Dédée F Murrell
Journal:  Int J Womens Dermatol       Date:  2015-02-26

Review 3.  Investigation of comorbid autoimmune diseases in women with autoimmune bullous diseases: An interplay of autoimmunity and practical implications.

Authors:  Meropi Karakioulaki; Dedee F Murrell; Aikaterini Kyriakou; Aikaterini Patsatsi
Journal:  Int J Womens Dermatol       Date:  2022-10-07

4.  A Novel Derivative of (-)mycousnine Produced by the Endophytic Fungus Mycosphaerella nawae, Exhibits High and Selective Immunosuppressive Activity on T Cells.

Authors:  Li-Wei Wang; Jin-Liang Wang; Jing Chen; Jia-Jie Chen; Jia-Wei Shen; Xiao-Xiao Feng; Christian P Kubicek; Fu-Cheng Lin; Chu-Long Zhang; Feng-Yang Chen
Journal:  Front Microbiol       Date:  2017-07-05       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.